(1)
Joy Artin; Yumn A. Elsabagh; Laila Rashed; Mohamed A. Hussein. Proprotein Convertase Subtilisin Kexin 9 (PCSK9) in Patients With Diffuse Systemic Sclerosis: A Marker of Disease Activity and Severe Disease Manifestations With Potential Therapeutic Implementations. Archives of Rheumatology 2023, 38, 249-256.